Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04967365
Other study ID # 843844
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 27, 2021
Est. completion date June 30, 2025

Study information

Verified date September 2023
Source University of Pennsylvania
Contact Martha AQ Curley, RN, PhD
Phone 215-573-9449
Email curley@upenn.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pediatric Intensive Care Unit (PICU) survival has increased substantially over the past three decades. Currently, an understanding of PICU morbidity and recovery among PICU survivors and their families is limited. Post-intensive care syndrome (PICS) consists of new or worsening impairments in physical, cognitive, or mental health status that arise and may persist after critical illness. The characteristics of PICS in children (PICS-p) are unknown. The objective of this study is to learn about pediatric recovery from critical illness to guide future intervention research to optimize child and family health.


Description:

PICS-p is a prospective longitudinal cohort study of pediatric patients experiencing 3 or more days of intensive care therapies at one of approximately 30 U.S. PICUs to evaluate child and family outcomes over two years post-PICU discharge. We will compare outcomes of these PICU patients with a control group of patients who received an overnight PICU stay but did not receive intensive care therapies, as well as with published quality of life data from the general and chronically ill populations. Children and their families will be enrolled locally from each PICU, their baseline data will be collected by local research staff, and their post-discharge outcomes will be followed centrally from the University of Pennsylvania and the Seattle Children's Research Institute. Our specific aims are to determine the physical, cognitive, emotional, and social health outcomes and trajectory of recovery in a population of children post-critical illness; to determine the baseline health, presenting problem, and PICU factors associated with impaired physical, cognitive, emotional, and social outcomes among PICU survivors; and to determine the emotional and social health outcomes in parents and siblings of PICU survivors. Our primary goal is to explicate the impact of pediatric critical illness over a two-year period of time to guide future intervention research to optimize child and family outcomes. Our overall goal is to improve the health and well-being of PICU survivors and their families.


Recruitment information / eligibility

Status Recruiting
Enrollment 750
Est. completion date June 30, 2025
Est. primary completion date June 30, 2025
Accepts healthy volunteers No
Gender All
Age group 1 Month to 16 Years
Eligibility Case Inclusion criteria: 1. Current admission is the child's first PICU (including pediatric subspecialty ICU) admission 2. Patient age =4 weeks and =44 weeks corrected gestational age and <16 years (has not yet reached 16th birthday) on PICU admission 3. At least one parent/legal guardian (=18 years of age or considered emancipated) living with the potential subject 4. PICU LOS of 3 days (covering at least 3 nights from midnight to 7am) in which the patient received intensive care therapies for organ dysfunction (for example, invasive mechanical ventilation, vasopressors/inotropes, acute renal replacement therapy, or other extracorporeal therapies). 5. Anticipated patient discharge to home (directly or indirectly after a stay in another facility) Case Exclusion criteria: 1. Patient history of neonatal intensive care unit hospitalization 2. Life expectancy not anticipated to be more than one year (e.g., active do not resuscitate [DNR] plan or actively managed by the palliative care team for end-of-life symptom management) 3. Patient in foster care or ward of the state Control subjects: As above but will be PICU patients who received an overnight PICU stay (<36 hours covering one midnight to 7am time period) that did not include intensive care therapies. Post-operative children who were intubated/extubated in the operating room/PACU (or intubated in the operating room and extubated in the PICU on arrival and prior to parent presence at the bedside) can be enrolled as control subjects. Control subjects will be frequency matched to cases on age group, sex, and medical complexity, that is, complex chronic disease (C-CD), noncomplex chronic disease (NC-CD), and without CD on a 2:1 case:control ratio. Family Subjects: At least one eligible parent/legal guardian must be willing to participate. In addition, up to two cognitively capable siblings (PCPC of 1 or 2) aged 8 to <16 years, who live with the patient, and who have not been ICU hospitalized will be invited to participate. If more than two siblings are eligible, the two siblings with the next birthday (regardless of birth year) will be invited to participate.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Children's Hospital of Atlanta Atlanta Georgia
United States Children's Hospital Colorado Aurora Colorado
United States Dell Children's Medical Center of Central Texas Austin Texas
United States Charlotte R Bloomberg Children's Center Baltimore Maryland
United States Alabama Children's Hospital Birmingham Alabama
United States UNC Children's Hospital Chapel Hill Chapel Hill North Carolina
United States Ann & Robert H Lurie Children's Hospital of Chicago Chicago Illinois
United States Comer Children's Hospital Chicago Illinois
United States Rainbow Babies and Children's Hospital Cleveland Ohio
United States Nationwide Children's Hospital Columbus Ohio
United States Children's Medical Center Dallas Dallas Texas
United States CS Mott Children's Hospital Detroit Michigan
United States Connecticut Children's Medical Center Hartford Connecticut
United States Texas Children's Hospital Houston Texas
United States Riley Children's Health at Indiana University Indianapolis Indiana
United States Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
United States Arkansas Children's Hospital Little Rock Arkansas
United States Annopinder Bhalla MD Los Angeles California
United States Norton Children's Hospital Louisville Kentucky
United States LeBonheur Children's Hospital Memphis Tennessee
United States Massonic Children's Hospital Minneapolis Minnesota
United States Lucille Packard Children's Hospital Stanford Palo Alto California
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States Doernbecher Children's Hospital Portland Oregon
United States Children's Hospital of Richmond Richmond Virginia
United States Mayo Clinic Rochester Minnesota
United States St Louis Children's Hospital Saint Louis Missouri
United States Primary Children's Hospital Salt Lake City Utah
United States Seattle Children's Hospital Seattle Washington
United States Children's National Hospital Washington District of Columbia
United States Brenner Children's Hospital Winston-Salem North Carolina

Sponsors (3)

Lead Sponsor Collaborator
University of Pennsylvania Boston Children's Hospital, Seattle Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Health related quality of life (HRQOL) - Patient PedsQL™ 4.0 Generic Core or Infant Scales (self report) Two years
Primary Health related quality of life (HRQOL) - Parent PedsQL™ 4.0 Generic Core or Infant Scales (parent report) Two years
Secondary Fatigue - Patient PedsQL™ Multidimensional Fatigue Scale v3.0 (self report) Two Years
Secondary Fatigue - Parent PedsQL™ Multidimensional Fatigue Scale v3.0 (parent report) Two Years
Secondary Sleep - Patient PROMIS Pediatric Sleep Disturbance - Short Form 4a and Pediatric Sleep-Related Impairment - Short Form 4a (self report) Two Years
Secondary Sleep - Parent PROMIS Sleep Disturbance - Short Form 4a and Sleep-Related Impairment - Short Form 4a (parent report) Two Years
Secondary Cognitive Functioning - Patient PedsQL™ Cognitive Functioning Scale and Pediatric Cerebral Performance Category (PCPC) Two Years
Secondary Cognitive Functioning - Parent PedsQL™ Cognitive Functioning Scale (parent report) and Pediatric Cerebral Performance Category (PCPC) (parent report) Two Years
Secondary Pain - Patient PedsQL™ Pediatric Pain Questionnaire and PROMIS Pediatric Pain Interference - Short Form 8a (self report) Two Years
Secondary Post Traumatic Stress Disorder (PTSD)- Patient Child PTSD Symptom Scale for DSM-5 (CPSS-V) (self report) Two Years
Secondary Post Traumatic Stress Disorder (PTSD)- Parent Young Child PTSD Screen - Revised PICU (YCPS R - PICU) (parent report); PTSD Checklist for DSM-5 (PCL-5) (parent report) Two Years
Secondary Strengths and Difficulties - Patient Strengths and Difficulties Questionnaire (SDQ) Two Years
Secondary Strengths and Difficulties - Sibling Strengths and Difficulties Questionnaire (SDQ) Two Years
Secondary Hope - Patient Children's Hope Scale (CHS) Two Years
Secondary Hope - Sibling Children's Hope Scale (CHS) Two Years
Secondary Growth and Development - Patient Survey of Well-being of Young Children (SWYC) - Milestones only (parent report) Two Years
Secondary Functional status - Patient Functional Status Scale (FSS) and Pediatric Overall Performance Category (POPC) (parent report) Two Years
Secondary Family impact PedsQL™ Family Impact Module v2.0 (parent report) Two years
Secondary Growth - Parent Post-traumatic Growth Inventory - Short Form (PTGI-SF) (parent self report) Two Years
Secondary Depression - Parent Patient Health Questionnaire-4 (PHQ-4) (parent self report) Two years
Secondary HRQOL - Sibling PedsQL Version 4.0 Generic Core Scales (sibling self report) Two Years
Secondary Caregiving - Sibling Multidimensional Assessment of Caring Activities (MACA-YC18) (sibling self report) Two Years
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness